|
Attomole quantitation of protein separations with accelerator mass spectrometry
|
journal
|
June 2001 |
|
Bioanalytics for Human Microdosing: Part IX. Bioanalytical Methods of Studying Metabolism
|
other
|
May 2012 |
|
Accelerator Mass Spectrometry in Pharmaceutical Development
|
other
|
January 2012 |
|
Verification of Therapeutic Effect through Accelerator Mass Spectrometry‐Based Single Cell Level Quantification of hESC‐Endothelial Cells Distributed into an Ischemic Model
|
journal
|
May 2023 |
|
Capillary electrophoresis of catecholamines with laser‐induced fluorescence intensified charge‐coupled device detection
|
journal
|
March 2001 |
|
A Phase 1 Study to Assess Mass Balance and Absolute Bioavailability of Zimlovisertib in Healthy Male Participants Using a 14C‐Microtracer Approach
|
journal
|
May 2022 |
|
A microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistance
|
journal
|
March 2011 |
|
A diagnostic microdosing approach to investigate platinum sensitivity in non-small cell lung cancer: Diagnostic microdosing approach
|
journal
|
May 2017 |
|
Single sample extraction protocol for the quantification of NAD and NADH redox states in Saccharomyces cerevisiae
|
journal
|
October 2008 |
|
Intrinsic Erythrocyte Labeling and Attomole Pharmacokinetic Tracing of14C-Labeled Folic Acid with Accelerator Mass Spectrometry
|
journal
|
May 1999 |
|
Parallel Accelerator and Molecular Mass Spectrometry Measurement of Carbon-14-Labeled Analytes
|
book
|
October 2021 |
|
The History of AMS, its Advantages over Decay Counting: Applications and Prospects
|
book
|
January 1992 |
|
Radiocarbon Accelerator Mass Spectrometry: Background, Precision and Accuracy
|
book
|
January 1992 |
|
The Dynamics of Folic Acid Metabolism in an Adult Given a Small Tracer Dose of 14C-Folic Acid
|
book
|
January 1998 |
|
Dual isotope test for assessing β-carotene cleavage to vitamin A in humans
|
journal
|
August 2002 |
|
Kinetics of 14C distribution after tracer dose of 14C‐lutein in an adult woman
|
journal
|
October 2005 |
|
Microdosing as a Potential Tool to Enhance Clinical Development of Novel Antibiotics: A Tissue and Plasma PK Feasibility Study with Ciprofloxacin
|
journal
|
January 2022 |
|
Pharmacokinetics, Disposition, and Biotransformation of [14C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous Infusion
|
journal
|
January 2024 |
|
Application of accelerator mass spectrometry (AMS) for high-sensitivity measurements of 14CO2 in long-term studies of fat metabolism
|
journal
|
April 1996 |
|
Long-term kinetic study of β-carotene, using accelerator mass spectrometry in an adult volunteer
|
journal
|
November 2000 |
|
Quantitating Isotopic Molecular Labels with Accelerator Mass Spectrometry
|
book
|
January 2005 |
|
Accelerator Mass Spectrometry for Biomedical Research
|
book
|
January 2005 |
|
Quantifying exploratory low dose compounds in humans with AMS
|
journal
|
June 2011 |
|
Impact of phenanthrene co-administration on the toxicokinetics of benzo[a]pyrene in humans. UPLC-accelerator mass spectrometry following oral microdosing
|
journal
|
September 2023 |
|
Retrospective Birth Dating of Cells in Humans
|
journal
|
July 2005 |
|
Dynamics of Hippocampal Neurogenesis in Adult Humans
|
journal
|
June 2013 |
|
Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers
|
journal
|
June 2011 |
|
Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP
|
journal
|
January 2022 |
|
The formation of AFB1-macromolecular adducts in rats and humans at dietary levels of exposure
|
journal
|
April 2004 |
|
Pharmacokinetics of [14C]-Benzo[a]pyrene (BaP) in humans: Impact of Co-Administration of smoked salmon and BaP dietary restriction
|
journal
|
May 2018 |
|
Measuring stable carbon and nitrogen isotopes by IRMS and 14C by AMS on samples with masses in the microgram range: Performances of the system installed at CEDAD-University of Salento
|
journal
|
October 2017 |
|
HPLC-Parallel accelerator and molecular mass spectrometry analysis of 14C-labeled amino acids
|
journal
|
February 2023 |
|
Quantification of azacitidine incorporation into human DNA/RNA by accelerator mass spectrometry as direct measure of target engagement
|
journal
|
August 2021 |
|
Development of a method for fast and automatic radiocarbon measurement of aerosol samples by online coupling of an elemental analyzer with a MICADAS AMS
|
journal
|
October 2015 |
|
An interface for the direct coupling of small liquid samples to AMS
|
journal
|
October 2015 |
|
Operation of the “Small” BioAMS spectrometers at CAMS: Past and future prospects
|
journal
|
October 2015 |
|
Status report: Implementation of gas measurements at the MAMS 14 C AMS facility in Mannheim, Germany
|
journal
|
November 2017 |
|
Trials and tribulations in the first three years in operation of the SSAMS for biomedical 14C-AMS at LLNL
|
journal
|
January 2019 |
|
Translating dosimetry of Dibenzo[def,p]chrysene (DBC) and metabolites across dose and species using physiologically based pharmacokinetic (PBPK) modeling
|
journal
|
March 2022 |
|
Benzo[a]pyrene toxicokinetics in humans following dietary supplementation with 3,3′-diindolylmethane (DIM) or Brussels sprouts
|
journal
|
February 2023 |
|
Analysis of aminofluorescein–fatty acid derivatives by capillary electrophoresis with laser-induced fluorescence detection at the attomole level: application to mycobacterial fatty acids
|
journal
|
October 2002 |
|
Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses
|
journal
|
September 1999 |
|
Comparative biotransformation studies of MeIQx and PhIP in animal models and humans
|
journal
|
September 1999 |
|
Online 13C and 14C Gas Measurements by EA-IRMS–AMS at ETH Zürich
|
journal
|
October 2016 |
|
A Continuous-Flow Gas Interface of a Thermal/Optical Analyzer With14C AMS for Source Apportionment of Atmospheric Aerosols
|
journal
|
November 2016 |
|
Accelerator mass spectrometry
|
journal
|
June 1995 |
|
A High-Throughput Method for the Conversion of CO 2 Obtained from Biochemical Samples to Graphite in Septa-Sealed Vials for Quantification of 14 C via Accelerator Mass Spectrometry
|
journal
|
May 2003 |
|
Precision and Accuracy in the Quantitative Analysis of Biological Samples by Accelerator Mass Spectrometry: Application in Microdose Absolute Bioavailability Studies
|
journal
|
June 2011 |
|
Ultrahigh Efficiency Moving Wire Combustion Interface for Online Coupling of High-Performance Liquid Chromatography (HPLC)
|
journal
|
December 2011 |
|
Directly Coupled High-Performance Liquid Chromatography–Accelerator Mass Spectrometry Measurement of Chemically Modified Protein and Peptides
|
journal
|
March 2013 |
|
Automated Combustion Accelerator Mass Spectrometry for the Analysis of Biomedical Samples in the Low Attomole Range
|
journal
|
July 2014 |
|
HPLC−Accelerator MS Measurement of Atrazine Metabolites in Human Urine after Dermal Exposure
|
journal
|
August 1999 |
|
Human Microdosing with Carcinogenic Polycyclic Aromatic Hydrocarbons: In Vivo Pharmacokinetics of Dibenzo[ def,p ]chrysene and Metabolites by UPLC Accelerator Mass Spectrometry
|
journal
|
September 2016 |
|
Room-Temperature Optical Detection of 14CO2 below the Natural Abundance with Two-Color Cavity Ring-Down Spectroscopy
|
journal
|
October 2022 |
|
Human in Vivo Pharmacokinetics of [ 14 C]Dibenzo[ def,p ]chrysene by Accelerator Mass Spectrometry Following Oral Microdosing
|
journal
|
December 2014 |
|
Microdose Study of 14C-Acetaminophen With Accelerator Mass Spectrometry to Examine Pharmacokinetics of Parent Drug and Metabolites in Healthy Subjects
|
journal
|
November 2010 |
|
Dynamics of fat cell turnover in humans
|
journal
|
May 2008 |
|
Dynamics of human adipose lipid turnover in health and metabolic disease
|
journal
|
September 2011 |
|
Big physics, small doses: the use of AMS and PET in human microdosing of development drugs
|
journal
|
March 2003 |
|
Phase 0/microdosing approaches: time for mainstream application in drug development?
|
journal
|
September 2020 |
|
In vivo tracking of 14C thymidine labeled mesenchymal stem cells using ultra-sensitive accelerator mass spectrometry
|
journal
|
January 2021 |
|
Two-color, intracavity pump–probe, cavity ringdown spectroscopy
|
journal
|
September 2021 |
|
Human vitamin B12 absorption measurement by accelerator mass spectrometry using specifically labeled 14C-cobalamin
|
journal
|
April 2006 |
|
Measurement of 7,8-dihydro-8-oxo-2'-deoxyguanosine metabolism in MCF-7 cells at low concentrations using accelerator mass spectrometry
|
journal
|
June 2007 |
|
Mid-infrared trace detection with parts-per-quadrillion quantitation accuracy: Expanding frontiers of radiocarbon sensing
|
journal
|
March 2024 |
|
Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA.
|
journal
|
July 1990 |
|
Attomole Detection of in Vivo Protein Targets of Benzene in Mice
|
journal
|
November 2002 |
|
Kinetic modeling of folate metabolism through use of chronic administration of deuterium-labeled folic acid in men
|
journal
|
January 1997 |
|
Quantitation of in vivo human folate metabolism
|
journal
|
September 2004 |
|
A feasibility study quantifying in vivo human α-tocopherol metabolism
|
journal
|
December 2006 |
|
Excentral cleavage of β-carotene in vivo in a healthy man
|
journal
|
March 2007 |
|
Dose-response studies of MeIQx in rat liver and liver DNA at low doses
|
journal
|
January 1995 |
|
Dose‐linearity of the pharmacokinetics of an intravenous [14C]midazolam microdose in children
|
journal
|
July 2019 |
|
An Investigation of the Metabolism and Excretion of KD101 and Its Interindividual Differences: A Microtracing Mass Balance Study in Humans
|
journal
|
September 2020 |
|
Strategic, feasibility, economic, and cultural aspects of phase 0 approaches
|
journal
|
April 2022 |
|
Interplay of Dissolution, Solubility, and Nonsink Permeation Determines the Oral Absorption of the Hedgehog Pathway Inhibitor GDC-0449 in Dogs: An Investigation Using Preclinical Studies and Physiologically Based Pharmacokinetic Modeling
|
journal
|
July 2010 |
|
An Innovative Approach to Characterize Clinical ADME and Pharmacokinetics of the Inhaled Drug Nemiralisib Using an Intravenous Microtracer Combined with an Inhaled Dose and an Oral Radiolabel Dose in Healthy Male Subjects
|
journal
|
October 2019 |
|
Investigation of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of the HIV-1 Maturation Inhibitor GSK3640254 Using an Intravenous Microtracer Combined with EnteroTracker for Biliary Sampling
|
journal
|
November 2022 |
|
Biotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and Humans
|
journal
|
April 2023 |
|
Application of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in Humans
|
journal
|
April 2023 |
|
The Absolute Bioavailability and Absorption, Metabolism, and Excretion of Ipatasertib, a Potent and Highly Selective Protein Kinase B (Akt) Inhibitor
|
journal
|
October 2023 |
|
Characterization of Pharmacokinetics, Biotransformation and Elimination of Pomotrelvir Orally Administered in Healthy Male Adults Using Two [14C]-Labeled Microtracers with Separate Labeling Positions
|
journal
|
December 2023 |
|
Evidence for Cardiomyocyte Renewal in Humans
|
journal
|
April 2009 |
|
Carbon-14: Direct Detection at Natural Concentrations
|
journal
|
November 1977 |
|
Radiocarbon Dating Using Electrostatic Accelerators: Negative Ions Provide the Key
|
journal
|
November 1977 |
|
The Urinary Metabolite Profile of the Dietary Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5- b ]Pyridine Is Predictive of Colon DNA Adducts after a Low-Dose Exposure in Humans
|
journal
|
November 2006 |
|
Tamoxifen Forms DNA Adducts in Human Colon after Administration of a Single [ 14 C]-Labeled Therapeutic Dose
|
journal
|
July 2007 |
|
Microdose-Induced Drug–DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice
|
journal
|
November 2016 |
|
Oxaliplatin–DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy
|
journal
|
April 2020 |
|
Effects of Chlorophyll and Chlorophyllin on Low-Dose Aflatoxin B 1 Pharmacokinetics in Human Volunteers
|
journal
|
December 2009 |
|
Age of Collagen in Intracranial Saccular Aneurysms
|
journal
|
June 2014 |
|
Absorption and retinol equivalence of β-carotene in humans is influenced by dietary vitamin A intake
|
journal
|
June 2003 |
|
Determination of IL-23 Pharmacokinetics by Highly Sensitive Accelerator Mass Spectrometry and Subsequent Modeling to Project IL-23 Suppression in Psoriasis Patients Treated with Anti-IL-23 Antibodies
|
journal
|
June 2019 |
|
The use of isotopes in the determination of absolute bioavailability of drugs in humans
|
journal
|
May 2006 |
|
Absorption, Metabolism, and Excretion of ACT-1004-1239, a First-In-Class CXCR7 Antagonist: In Vitro, Preclinical, and Clinical Data
|
journal
|
March 2022 |
|
Separation of Lipoproteins for Quantitative Analysis of 14C-Labeled Lipid-Soluble Compounds by Accelerator Mass Spectrometry
|
journal
|
February 2024 |
|
14C-Cobalamin Absorption from Endogenously Labeled Chicken Eggs Assessed in Humans Using Accelerator Mass Spectrometry
|
journal
|
September 2019 |
|
A Minute Dose of 14C-β-Carotene Is Absorbed and Converted to Retinoids in Humans
|
journal
|
June 2009 |
|
Accelerator mass spectrometry for quantification of micro- and therapeutic-dose diclofenac in microdialysis samples
|
journal
|
August 2022 |